Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Debt to Equity: 2016-2025

Historic Debt to Equity for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $2.07.

  • Collegium Pharmaceutical's Debt to Equity fell 22.88% to $2.07 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.63, marking a year-over-year increase of 18.05%. This contributed to the annual value of $2.69 for FY2024, which is 29.73% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Debt to Equity of $2.07 as of Q3 2025, which was down 17.68% from $2.52 recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Debt to Equity peaked at $3.20 during Q1 2022, and registered a low of $0.49 during Q3 2021.
  • Its 3-year average for Debt to Equity is $2.33, with a median of $2.51 in 2023.
  • Its Debt to Equity has fluctuated over the past 5 years, first slumped by 54.46% in 2021, then soared by 508.57% in 2022.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Debt to Equity stood at $0.54 in 2021, then surged by 430.20% to $2.87 in 2022, then dropped by 27.90% to $2.07 in 2023, then increased by 29.73% to $2.69 in 2024, then decreased by 22.88% to $2.07 in 2025.
  • Its last three reported values are $2.07 in Q3 2025, $2.52 for Q2 2025, and $2.56 during Q1 2025.